BioWorld

Dec. 12, 2000

View Archived Issues

Gilead Placement Of Convertible Notes To Gross Company $250M

Read More

Other News To Note

Read More

Anadys Targets New Technology Platform Expansion With $21.2M

Read More

BioChem Pharma, Shire Plan To Merge In $4B Stock Swap

Read More

BioTransplant Acquiring Eligix In Stock Deal Valued At $55M

Read More

Mutations In Hepatitis C Genome Reveal Proteins That Spur, Deter Pathogen's Replicative Strategies

Read More